Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Commitments and Contingent Liabilities - Schedule of Royalty Rates (Details)

v3.20.1
Commitments and Contingent Liabilities - Schedule of Royalty Rates (Details)
Dec. 31, 2019
Royalty payment on net sale, reduced percentage 2.00%
Leukemia Related Products [Member]  
Royalty payment on net sale, percentage 3.00%
Royalty payment on fixed sublicence income with no sublicence income on sales, percentage 20.00%
Royalty payment on fixed sublicence income with sublicence income on sales, percentage 10.00%
Other Product [Member]  
Royalty payment on net sale, percentage 2.50%
Royalty payment on fixed sublicence income with no sublicence income on sales, percentage 15.00%
Royalty payment on fixed sublicence income with sublicence income on sales, percentage 7.50%